Shares of Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) are trading higher Monday after the pharmaceutical company reported positive data from an ongoing trial. What To Know: Recursion ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...

After 12 years leading Utah-based techbio company Recursion, CEO Chris Gibson is stepping down. Recursion’s R&D head and Chief Commercial Officer Najat Khan will become CEO effective Jan. 1. Gibson co ...

Recursion Pharmaceuticals trades at a $2.65bn valuation despite slow clinical progress, high cash burn, and no late-stage assets. RXRX's AI-driven drug discovery model is ambitious, but pipeline value ...

About 10.6 percent of people are left-handed. It is still not well understood why some people prefer to write, draw, and perform other activities with their left hand, while most people prefer to use ...

NATIONAL HARBOR, Md. — Even with dozens or hundreds of sensor satellites in orbit to spot incoming weapons, U.S. military leaders say defending against the most advanced missile threats will require ...

Whenever I give an interview about scientific research on left-handedness, at one point or another, the interviewer will ask the question of what things left-handers have an advantage in over ...

In recent years, the United States has seen an increase in the number of left-wing terrorism attacks and plots, although such violence has risen from very low levels and remains much lower than ...

Because there’s a silver lining for most things in life, maybe there’s also one for ABC’s craven (if brief) suspension, under thuggish government pressure, of Jimmy Kimmel’s late-night talk show. To ...